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Abstract: In medical diagnostics, rapid detection of
pathogenic bacteria from body fluids is one of the basic is-
sues. Most state-of-the-art methods require optical label-5
ing, increasing the complexity, duration and cost of the
analysis. Therefore, there is a strong need for developing
selective sensory devices based on label-free techniques,
in order to increase the speed, and reduce the cost of detec-
tion. In a recent paper, we have shown that an integrated10
optical Mach-Zehnder interferometer, a highly sensitive
all-optical device made of a cheap photopolymer, can be
used as a powerful lab-on-a-chip tool for speci?c, label-
free detection of proteins. By proper modifications of this
technique, our interferometric biosensor was combined15
with a microfluidic system allowing the rapid and specific
detection of bacteria from solutions, having the surface of
the sensor functionalized by bacterium-specific antibod-
ies. The experiments proved that the biosensor was able
to detect Escherichia coli bacteria at concentrations of 10620
cfu/ml within a fewminutes, that makes our device an ap-
propriate tool for fast, label-free detection of bacteria from
body fluids such as urine or sputum. On the other hand,
possible applications of the devicemay not be restricted to
medical microbiology, since bacterial identification is an25
important task in microbial forensics, criminal investiga-
tions, bio-terrorism threats and in environmental studies,
as well.
Keywords: Biosensor, Integrated optics, Mach-Zehnder in-
terferometer, microfluidics, E. coli, bacteria30
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1 Introduction
Bacteria analysis and the identification ofmicroorganisms
to the species level and beyond is a key task of microbiol-
ogy. Accurate and definitivemicroorganism identification,
including bacterial identification and pathogen detection, 35
is essential for the correct disease diagnosis, treatment of
infection and trace-back of disease outbreaks associated
with microbial infections. Traditionally this is achieved
by carrying out labour-intensive and time-consuming bio-
chemical assays. Traditional methods of bacterial identifi- 40
cation rely onphenotypic identificationof the causative or-
ganism using stainings (for example: Gram-staining), cul-
ture and numerous biochemical methods and antibiotic
susceptibility test. Many of these are used decades ago,
although in recent years there has been a need on up- 45
dating or revising the already existing methodology. The
traditional microbiologic methods of microbial detection
tend to be labor-intensive and take more than a day to ob-
tain results and even more to get the antibiotic suscepti-
bility results. These have resulted in numerous rapid tech- 50
niques. Rapidmethods for microbial detection can be sen-
sitive, precise, and relatively quick. However, these mod-
ern methods are more expensive than their conventional
counterpart, and the direct cost of the test or in the time
to prepare the sample for testing takes more. Although 55
it is well-known by the users that obtaining results more
quickly is worth the cost of these systems.
Rapid microbiological tests
Rapid microbiological tests and reagents range from sim-
ple biochemical or immunological techniques to direct 60
specimen tests to a combination of sophisticated instru-
mentation, software, consumables, and reagents (as re-
cent reviews, see [1, 2]). Specific detection, quantitative, or
identification methodologies may be employed, depend-
ing upon the desired approach, epidemiological signifi- 65
cance, and degree of identification required. Many of the
current rapid tests and reagents on the market today re-
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quire a relatively large number of living microbial cells be
present in the sample. Moreover, since testing may be per-
formed in a variety of locations— hospital settings, or re-
search and reference labs—it is important to understand
the technical capabilities that are required. Those include5
the method sensitivity and specificity, expectations of the
system or method, and the degree of training required of
the operator.
One type of common rapid test method involves the
use of miniaturized biochemical identification devices.10
These disposable devices perform a range of biochemical
tests simultaneously. They are generally designed to iden-
tify specific bacterial species. These units simplify conven-
tional testing procedures by eliminating the need for mul-
tiple tubed or platedmedia; they are generally space, time,15
and cost savers.
Some rapid tests and reagents involve using antibod-
ies or nucleic acids to detect pathogens or toxins. Of these,
antibodies are the most versatile and may be used in a va-
riety of kits. These rapid kits take advantage of antibody-20
antigen interactions unique to a particular microorgan-
ism. A latex agglutination test works in thismanner: beads
are coated with plasma antibodies unique to a particular
pathogen. If the reaction turns positive, the latex beads
will cause the bacterium to clump or agglutinate. If the25
beads are colored and are placed on a white background,
it is easy to detect a positive reaction by observing visible
clumping.
Enzyme-linked immunosorbent assays and enzyme
immunoassays rely on antibody-antigen interactions30
which can be placed on a microplate or combined on a
membrane and incorporated into a lateral flow kit. An-
tibody screening and toxin tests are examples of these
types of kits and are most useful for direct specimen test-
ing when a result is needed quickly to aid in the diagnosis35
of disease.
Polymerase chain reaction-based kits (PCR) use an en-
zyme to replicate a small portion of a target microorgan-
ism’s DNA. The reaction involves attaching a marker to
the target DNA so that it is more easily visualized. The ad-40
vantage of this rapid test format is that very small num-
bers of a pathogen can be detected rather quickly. How-
ever, PCR-based methods cannot distinguish between vi-
able and nonviable cells, so resultsmust be interpreted ac-
cordingly.45
These are just a few examples of what rapid test and
reagent kits can do, but the goal of rapid testing is the
same no matter the application: to provide accurate iden-
tification and rapid communication to interested parties in
order to improve outcomes. Some test kits can provide re-50
sults within four to 24 hours.
Cost may be the main downside to some of the newest
forms of rapid tests: there is a price to pay for research and
development and to promote innovative technologies. For
larger laboratories, economics of scale and reduced labor 55
costsmayoffset the cost per test: speedy results carry a cost
benefit. Conversely, costsmay be significant enough to put
some of the more recent high-tech rapid methods out of
reach for smaller laboratories, especially when there is no
foreseeable cost benefit in results or if the reading win- 60
dow does not fit into a smaller laboratory’s scheduling re-
strictions. This is also in conflict with recent requirements,
when real-life measurement systems, like POCT (Point Of
Care Testing), NPT (Near Patient Testing) are emerging
in more and more areas of clinical pathology, infectivol- 65
ogy, toxicology, food and environmental protection. Ro-
bustness of the analytical techniques should meet the re-
quirement of having operating personnel with only low or
medium level of training in the area of biomedical analyt-
ics. Hence, there is an urgent need for cost-effective detec- 70
tionmethods allowing automated data collection and pro-
cessing.
In this paper, we report on the development of a lab-
on-a-chip tool for rapid detection of bacteria from small
amounts of fluids. The device is built around a biosensor 75
adapted to this purpose, based on an integrated optical
Mach-Zehnder interferometer [3]. After giving a short in-
troduction to its operation priciple, we give a detailed de-
scription of the structure of the device, and show the re-
sults of test measurements demonstrating the functional- 80
ity of the tool. Potential applications of the results in med-
ical diagnostics and beyond, is also discussed.
2 Materials and Methods
2.1 Principle of operation
Integrated optical interferometric biosensors combine the 85
detection of evanescent field with the measurement of
phase alteration.
The operation is based on the specific binding of the
target molecule or bacteria to the measuring arm of the in-
terferometer. This binding is realized by appropriate recog- 90
nition elements – for example receptors, antibodies, en-
zymes - immobilized to the waveguide surface. The bind-
ing of target objects causes a local refractive index change
at the sensor surface which effects the propagation of the
incoupled light in the waveguide via the evanescent field. 95
The resulting phase difference between the propagating
mode in the measuring and reference arms can be de-
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tected as an output intensity change due to the interfer-
ence (Fig. 1).
Figure 1: The operation of an interferometric biosensor is based
on the specific binding of the target molecule or bacteria to the
measuring arm of the interferometer. When the target object binds
to the to the surface a local refractive index change takes place,
resulting phase difference between the propagating mode in the
measuring and reference arm. The resulting intensity change at the
output can be detected.
The transmission function of the interferometer is si-
nusoidal, as it was demonstrated in [3] by illuminating an
auxiliary thin (4 µm) film of the chromoprotein bacteri-5
orhodopsin (bR) layered onto the reference arm of the in-
terferometer (see also in Fig. 2, below). Using saturating
light intensities (e.g., 100 mW/cm2 at 532 nm), two full pe-
riods (4pi phase shift) could be covered, that makes the
bR film suitable for adjusting the operating point of the10
interferometer to the highest sensitivity (i.e., to the mean
of the minimum and maximum output values) [3]. As we
have shown it earlier [4], under such conditions, the re-
fractive index change of the bacteriorhodopsin film is ca.
5·10−3. When using the integrated optical interferometer15
for biosensing purposes, however, by at least an order of
ofmagnitude smaller changes in the effective refractive in-
dex of the adlayer are estimated to occur upon the initial
binding of a sparse layer of proteins or cells on the surface
of the waveguide structure [5]. This implies that, during 20
the sensing process, the response of the interferometer re-
mains in the linear range. In addition, as pointed out in [6],
in first approximation the effective refractive index change
of the adlayer is proportional to the change of the adsorbed
mass, and to bulk concentration of the analyte. Hence, the 25
initial slope of the signal detected by our interferometric
sensor should be proportional to the concentration of the
bacteria to be detected.
2.2 Preparation of the biosensor
2.2.1 Integrated optical MZI 30
The Mach-Zehnder interferometer (MZI) was prepared by
photopolymerization of NOA81 optical adhesive (Norland
Products Inc., USA) by a so called direct laser writing tech-
nique that we used already for the preparation of micro-
machines and integrated optical structures [4, 7]. Briefly, 35
a microscope coverslip was spincoated by the adhesive
(2100 rpm, 120 s), and subsequently mounted on the mo-
torized X-Y stage (Märzhauser) of an inverted microscope
(Zeiss Axiovert 200) for writing. The beam of a laser diode
(NDV4313, Nichia Co., 405 nm, 20 mW) was focussed by a 40
microscope objective (10X, 0.25NA) onto the NOA81 layer.
By properly moving the motorized stage, the interferome-
ter structure was exposed into the layer. Where necessary,
the writing was stopped by blocking the laser beam by
a shutter (Uniblitz VS14S2ZM1R1-21, Vincent Associates). 45
Both the motorized stage and the shutter were controlled
by a computer. The cover slip was then thoroughly rinsed
in a 1:3mixture of Ethanol and Acetone, in order to remove
the unexposed parts. The width of the line of the interfer-
ometer (2 µm) was controlled by adjusting the focal spot 50
size of the microscope objective and the writing speed. In
order to have proper input and output facets, the ends of
the waveguide were cleaved by the help of a diamond cut-
ter (S90W, Thorlabs Inc.). Finally, the coverslip was glued
on a microscope slide also by NOA81 exposed by a 100- 55
Wmercury arch lamp. The optical connection was estabil-
ished by single-mode optical fibres (S630-HP, Thorlabs). A
beam of a laser diode (633 nm, 10 mW) was then coupled
into the optical fiber, whose other end was matched to the
input of the MZ interferometer by a micropositioner (DC- 60
3K, Märzhäuser Wetzlar GmbH & Co. KG, Germany), and
its optimal position was fixed by a photopolymer glue (OP-
66-LS, DymaxEuropeGmbH,Germany). Outcoupling from
the MZI was accomplished the same way (Fig. 2).
For measuring the transfer characteristics of the inter- 65
ferometer the red light of a laserdiode (633 nm, 10 mW)
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Figure 2: Schematic picture of the setup. Red light of a laserdiode
(633 nm, 10 mW) was coupled to the interferometer, the transmitted
light was guided to a photomultiplier and the signal was recorded
by a storage oscilloscope.
was coupled to the interferometer through the attached
single mode optical fibre. The output optical fibre guided
the transmitted red light to a photomultiplier (H5783-01,
Hamamatsu, Japan) and the signal was recorded by a stor-
age oscilloscope (WaveRunner 6100A, LeCroy, USA).5
2.2.2 Fabrication of PDMS microfluidic channels
For the test experiment with the immunological sensor,
microfluidic channels were prepared of PDMS by soft
lithography. First the mold was made from SU8 pho-
topolimer using negative photolitoghraphy. During the10
process a spincoated, soft baked (90 °C, 5 min) SU8
layer (30 µm) was exposed by UV light (λ≈ 365 nm, P ≈
76mW/cm2, Newport, Oriel 97435UV lamp) throughapho-
tomask. Then liquid PDMSprepolymer (degassed 1:10mix-
ture of Sylgard 184, Dow Corning) was poured over the15
master and cured for 30 miutes at 80°C. The PDMS replica
was then peeled from the master and holes were punched
for pipette tips at inlets and outlets. Thereafter the PDMS
was sealed above the Mach-Zehnder interferometer.
Figure 3: a, Schematic illustration of the microfluidic channel above
the Mach-zehnder interferometer. The inlet and outlet holes were
formed far from the waveguide to avoid possible damages. b, Pho-
tography of the ready made biosensor (silicone tubing and optical
fibers are attached)
To form the seal, the PDMS and the interferome- 20
ter were exposed to oxygen plasma (PDC-002, Harrick
Plasma), where 400 mtorr=53.3 Pa oxygene pressure was
maintained and 29.6W RF power was applied for 60 sec-
onds. Then the PDMS block was carefully positioned and
attached above the parallel parts of the Mach-Zehnder. 25
To improve the strength of the seal, the device was kept
overnight in an incubator at 40 °C. Finally pipette tipswere
fitted into the inlet and outlet holes and silicone tubing (d
= 1 mm) was attached (Fig. 3).
2.2.3 Waveguide functionalization 30
Themeasuring armwas functionalized to achieve the spe-
cific binding of the target bacteria Escherihica coli DH5 al-
pha. For filling up themicrofluidic channels syringe pump
and silicone pumping were used.
Before starting the functionalization the PDMS 35
channels were cleaned with ethanol. Then the mea-
suring arm was filled with 2% APTES solution ((3-
Aminopropyl)triethoxysilane 99% Sigma-Aldrich, diluted
with isopropanol) for 90 mins. After this the channels
were leached with isopropanol for 10 mins to remove 40
unbound APTES. The channels were dried with air and
washed with MilliQ water to remove physiabsorb APTES.
The device was cured at 100 °C for 6 mins on a hot plate to
strengthen the binding betweenAPTES and thewaveguide
surface. The second step was the filling of the channels 45
with 2.5% gluteraldehyde solution (Grade II, 25% in H2O,
Sigma-Aldrich, diluted with PBS (1X, pH 7.4)) for 2hours.
Thereafter the device was washed thoroughly with PBS
for 10 mins. Then the channels were filled with the an-
tibody solution (Anti-E. coli antibody - Azide free (Cat. 50
No.: ab48416), Abcam; diluted with PBS) for overnight.
Next day the device was leached with PBS to remove the
unbound antibodies. As a result of the functionalization
procedure an antibody adlayer formed on the surface of
the measuring arm. 55
2.2.4 E. Coli culture
Colonies of E. coli Dh5-alpha strain were maintained on
agar plates at 4∘C. Before the experiments, one colonywas
placed into 3 ml LB (lysogeny broth) medium in a sterile
polystyrene tube, and the bacteria were grown overnight 60
in a shaker incubator at 30∘C. Overnight cultures were di-
luted back in themorning 100 times, and cells were grown
until they reached an optical density of 0.5–0.8 at 600 nm
(OD 600). 1 ml of the cell culture was centrifuged (3000
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rpm, 10 min) and resuspended in PBS (phosphate saline
buffer) solution.
2.2.5 Testing the binding ability of anti-E. coli antibody
with ELISA
The binding ability of the goat polyclonal anti-E. coli IgG5
antibody (Abcam, Cat. No.: ab48416) was tested with an in
house constructed indirect ELISA. For the test,E. coliDH5α
strain was propagated on an agar plate for 24 hours. The
colonieswere collectedwith an inoculating loop anda sus-
pensionwasmade in phosphate buffered saline (PBS). The10
ELISA plate (R&D Systems, Cat. No.: DY994) was coated
overnight at 4°C with the serial dilution of the E. coli sus-
pension in a range from 101 to 106 fold dilution in a pres-
ence and absence of 0.5% formaldehyde (Reanal, 10492-1-
01-65). After coating, the fluid was aspirated and the plate15
was blocked with 1% bovine serum albumin (Sigma, Cat.
No.: A-6793) for two hours at room temperature followed
bywashing it three timeswith0.05%Tween20 (Sigma, Cat.
No.: 93773) in PBS. The anti-E.coli antibody was added as
a primary antibody in 1 µg/ml and 2 µg/ml concentrations20
and incubated for onehour at room temperature. The plate
was washed three times with 0.05% Tween20 in PBS. The
boundedprimary antibodywasdetectedwith aperoxidase
labelled rabbit anti-goat IgG antibody (Sigma-Aldrich, Cat.
No.: A5420) in 40000 fold dilution. After one hour in-25
cubation at room temperature the plate was washed five
times with 0.05% Tween20 in PBS followed by adding the
TMB substrate (Abcam, Cat. No.: ab171522). After 25 min-
utes the reactionwas stoppedwith 2N sulphuric acid (R&D
Systems, Cat. No.: DY994) and the plate was measured at30
450 nm with the reference filter of 690 nm. Formaldehyde
helped the immobilization of E. coli antigens on the plate
surface during the coating.
3 Results and discussion
3.1 ELISA measurements35
Prior to the biosensing experiments, the binding ability
of the goat polyclonal anti-E. coli IgG antibody was tested
with an in-house constructed indirect ELISA.
The experiments proved that the tested anti-E. coli
antibody could bind the E. coli antigens. The amount of40
the bounded primary antibody depended on its concen-
tration, the coating buffer and the amount of antigens on
the plate. The optical density was higher by use of higher
Figure 4: Testing the binding ability of the anti-E. coli antibody with
ELISA with different concentrations of primary antibody and coating
buffers (OD: optical density)
concentrations of anti-E. coli antibody, as well as by larger
amounts of the antigen. 45
3.2 Interferometric detection
The measurements were started after the above function-
alization process. Prior to the experiments, the operating
point of the device was set appropriately to achieve the
highest sensitivity (see 2.2.1). Then, the E. coli suspension 50
of 4·10−6 cfu/ml concentration was pumped into the mea-
suring reference channels at time zero. Fig. 5 shows sub-
sequent intensity changes of the light outcoupled from the
MZI. The time course of the light intensity change was fit-
ted by a single exponential, whose time constant was ca. 55
600 s, which was attributed to the binding process of bac-
teria to
the measuring arm of the interferometer. The arrange-
ment of the setup allowed a continuous visual control of
thebindingprocess byamicroscope. Fig. 6 showsa section 60
of the measuring arm with bacteria bound to the surface.
At the same time, no bindingwas observed at the reference
arm of the MZI (data not shown).
Note, however, that visual observation by the micro-
scope was used only to control that binding process goes 65
parallelly with the development of the ourput signal, it is
not an essential part of our device, whose arrangement
supports a full automatic control of the sensing process,
from the sample delivery to the detection of the signal.
The integrated optical structure combined with microflu- 70
idics, on the other hand, grants portability of the device,
fulfilling the requirements of state-of-the-art POC diagnos-
tics [8].
The time constant observed for binding is in a good
agreement with data of other studies got for characteristic 75
times of cell adsorption to solid surfaces [9, 10]. Note, how-
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Figure 5: Light intensity change at the output of the Mach-Zehnder
interferometer after pumping E. coli bacterium suspension above
the measuring arm at time zero. The zero value of the Y axis refers
to the mean of the minimum and maximum light intensities of the
sinusoidal transmission function of the interferometer, where the
operating point was adjusted prior to the measurement (see also
2.1). The curve could be fitted with a sigle exponential with a time
constant of 600 s (not shown).
Figure 6: Photograph of a section of the biosensor after binding
of the coli bacteria (dark spots) to the functionalized surface. The
upper stripe is part of the measuring arm of the MZI, while the lower
one is showing the microchannel wall.
ever, that the binding rate of the analyte should be pro-
portional to its concentration (see 2.1). Although the exact
calibration of our biosensor is to be the subject of follow-
up studies, according to our estimate based on the present
experiments, the detection limit in bacterium concentra- 5
tion is ca. 106 cfu/ml, which is comparable to characteris-
tic pathogene concentrations in sputum and urine [11, 12],
implying that our device is appropriate for screening such
body fluids. However, bacterium concentration in septic
blood is usually not exceeding 103 cfu/ml, meaning that 10
further improvement of the sensitivity of our technique
is necessary for testing blood samples. Note, at the same
time, that bacterial identification is used not only in medi-
cal microbiology, but also in microbial forensics, in crimi-
nal investigations, in bio-terrorism threats and in environ- 15
mental studies as well.
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